Login
Roast topics
Find topics
Find it!
From:
Asceneuron
(Uncensored)
subscribe
Ferrer acquires worldwide rights to ASN90, an O-GlcNAcase inhibitor from Asceneuron, exclusively to treat Progressive Supranuclear Palsy (PSP)
https://asceneuron.com/ferrer-acquires-worldwide-rights-to-asn90-an-o-glcnacase-inhibitor-from-asceneuron-exclusively-to-treat-progressive-supranuclear-palsy-psp/
links
backlinks
Tagged with:
divi
Roast topics
Find topics
Roast it!
L’article Ferrer acquires worldwide rights to ASN90, an O-GlcNAcase inhibitor from Asceneuron, exclusively to treat Progressive Supranuclear Palsy (PSP) est apparu en premier sur Asceneuron.
